Global Blood Culture Test Market by Product (Consumables, Instruments, and Software & Services), Method (Conventional and Automated), and Application (Bacterial, Fungal, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global blood culture tests market was valued at $3,900.00 million in 2019, and is estimated to reach $8,186.15 million by 2027, registering a CAGR of 9.3% from 2020 to 2027. A blood culture is a test that examines the presence of foreign bodies such as bacteria, yeast, and other microorganisms in the blood. Blood cultures are procedures done to detect an infection in the blood and identify the cause.
Growth of the global blood culture tests market is majorly driven by rise in geriatric population; alarming increase in prevalence of infectious diseases, sepsis, and bloodstream infection (BSIs); and surge in demand for diagnostic techniques. For instance, according to the Centers for Diseases Control and Prevention (CDP), about 250,000 cases of BSIs occur yearly, and among them 80,000 patients suffer from catheter-related BSIs. As per statistics provided by the UN Population Division, the total proportion of people above 65 years increased from 703 million in 2019, and is projected to reach 1.5 billion by 2050, globally. Around 30 million people across the globe were detected with bloodstream infection across the globe. Bloodstream infection ranges from 11% to 28% in the Eastern African countries. It has been observed from the report of the World Health Organization that 85% of the deaths from sepsis occur in low- and middle-income countries. Hence, increase in prevalence of BSIs and rise in geriatric population are expected to propel demand for blood culture tests, which, in turn, augments the market growth. Furthermore, blood culture tests play an important role in the global healthcare sector. This is attributed to the fact that the diagnostic device of blood culture tests is used for the diagnosis of infectious diseases such as bloodstream infection and sepsis. Moreover, rise in investment and activities in R&D actives by various healthcare sectors for development of new products such as consumable, instruments, and software drive the growth of the global market. Upsurge in investment in R&D sector is a strategy of venture for development of novel products and further aids to support the long-term growth of business. In addition, rise in adoption of new technology is expected to provide lucrative opportunity for the expansion of the blood culture tests market growth. For instance, in February 2020, Luminex Corporation announced the VERIGENE II respiratory Flex, which received its approval from the Food and Drug Administration for 510(k).
On the contrary, high cost of automated blood culture instruments along with a lack of skilled professionals & laboratory technicians are anticipated to restrain the market growth during the forecast period. For instance, the average selling price of polymerase chain reaction (PCR) is between $10,000 and $15,000 and the price for MALDI-TOF MS Systems is between $150,000 and $850,000. Moreover, dearth of skilled professionals may decrease the efficiency of result and increase in turnaround time for providing accurate results, thus limiting the market growth.
Depending on the product, the market is segmented into consumable, instruments, and software & services. On the basis of method, the market is fragmented into the conventional and automated. The applications covered in the study include bacteria, fungemia, and mycobacterial detection. On regional level, the blood culture tests market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
By Product
Growth of the global blood culture tests market is majorly driven by rise in geriatric population; alarming increase in prevalence of infectious diseases, sepsis, and bloodstream infection (BSIs); and surge in demand for diagnostic techniques. For instance, according to the Centers for Diseases Control and Prevention (CDP), about 250,000 cases of BSIs occur yearly, and among them 80,000 patients suffer from catheter-related BSIs. As per statistics provided by the UN Population Division, the total proportion of people above 65 years increased from 703 million in 2019, and is projected to reach 1.5 billion by 2050, globally. Around 30 million people across the globe were detected with bloodstream infection across the globe. Bloodstream infection ranges from 11% to 28% in the Eastern African countries. It has been observed from the report of the World Health Organization that 85% of the deaths from sepsis occur in low- and middle-income countries. Hence, increase in prevalence of BSIs and rise in geriatric population are expected to propel demand for blood culture tests, which, in turn, augments the market growth. Furthermore, blood culture tests play an important role in the global healthcare sector. This is attributed to the fact that the diagnostic device of blood culture tests is used for the diagnosis of infectious diseases such as bloodstream infection and sepsis. Moreover, rise in investment and activities in R&D actives by various healthcare sectors for development of new products such as consumable, instruments, and software drive the growth of the global market. Upsurge in investment in R&D sector is a strategy of venture for development of novel products and further aids to support the long-term growth of business. In addition, rise in adoption of new technology is expected to provide lucrative opportunity for the expansion of the blood culture tests market growth. For instance, in February 2020, Luminex Corporation announced the VERIGENE II respiratory Flex, which received its approval from the Food and Drug Administration for 510(k).
On the contrary, high cost of automated blood culture instruments along with a lack of skilled professionals & laboratory technicians are anticipated to restrain the market growth during the forecast period. For instance, the average selling price of polymerase chain reaction (PCR) is between $10,000 and $15,000 and the price for MALDI-TOF MS Systems is between $150,000 and $850,000. Moreover, dearth of skilled professionals may decrease the efficiency of result and increase in turnaround time for providing accurate results, thus limiting the market growth.
Depending on the product, the market is segmented into consumable, instruments, and software & services. On the basis of method, the market is fragmented into the conventional and automated. The applications covered in the study include bacteria, fungemia, and mycobacterial detection. On regional level, the blood culture tests market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global blood culture tests market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global blood culture tests market.
By Product
- Consumables
- Instruments
- Software & Services
- Conventional
- Automated
- Bacterial
- Fungal
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Arabia
- South Africa
- Rest of LAMEA
- Autobio Diagnostics Co., Ltd
- Becton, Dickinson and company (BD)
- bioM?rieux SA
- Bruker Corporation
- F. Hoffmann-La Roche Ltd
- Luminex Corporation
- Neogen Corporation (Abtek Biologicals)
- OpGen Inc.
- T2 Biosystems, Inc.
- Thermo Fisher Scientific Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s Five Forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of infectious diseases, bloodstream infection and sepsis
3.5.1.2.Rise in demand for advanced diagnostic techniques
3.5.1.3.Increase in R&D activities and strict regulation from government
3.5.1.4.Growing worldwide geriatric population
3.5.2.Restraints
3.5.2.1.High cost of automated blood culture instruments
3.5.2.2.Lack of skilled professionals and laboratory technicians
3.5.3.Opportunity
3.5.3.1.Increase in adoption of new technology
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the blood culture tests market
CHAPTER 4:BLOOD CULTURE TEST, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Market size and forecast, by region
4.2.2.Market analysis, by country
4.3.Instruments
4.3.1.Market size and forecast, by region
4.3.2.Market analysis, by country
4.4.Software and Services
4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country
CHAPTER 5:BLOOD CULTURE TESTS MARKET, BY METHOD
5.1.Overview
5.1.1.Market size and forecast
5.2.Conventional
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Automated
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:BLOOD CULTURE TESTS MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Bacterial
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Fungal
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Other
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:BLOOD CULTURE TEST MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.North America market size and forecast, by product
7.2.2.North America market size and forecast, by method
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by country
7.2.5.U.S.
7.2.5.1.U.S. market size and forecast, by product
7.2.5.2.U.S. market size and forecast, by method
7.2.5.3.U.S. market size and forecast, by application
7.2.6.Canada
7.2.6.1.Canada market size and forecast, by product
7.2.6.2.Canada market size and forecast, by method
7.2.6.3.Canada market size and forecast, by application
7.2.7.Mexico
7.2.7.1.Mexico market size and forecast, by product
7.2.7.2.Mexico market size and forecast, by method
7.2.7.3.Mexico market size and forecast, by application
7.3.Europe
7.3.1.Europe market size and forecast, by product
7.3.2.Europe market size and forecast, by method
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by country
7.3.5.Germany
7.3.5.1.Germany market size and forecast, by product
7.3.5.2.Germany market size and forecast, by method
7.3.5.3.Germany market size and forecast, by application
7.3.6.France
7.3.6.1.France market size and forecast, by product
7.3.6.2.France market size and forecast, by method
7.3.6.3.France market size and forecast, by application
7.3.7.UK
7.3.7.1.UK market size and forecast, by product
7.3.7.2.UK market size and forecast, by method
7.3.7.3.UK market size and forecast, by application
7.3.8.Italy
7.3.8.1.Italy market size and forecast, by product
7.3.8.2.Italy market size and forecast, by method
7.3.8.3.Italy market size and forecast, by application
7.3.9.Spain
7.3.9.1.Spain market size and forecast, by product
7.3.9.2.Spain market size and forecast, by method
7.3.9.3.Spain market size and forecast, by application
7.3.10.Rest of Europe
7.3.10.1.Rest of Europe market size and forecast, by product
7.3.10.2.Rest of Europe market size and forecast, by method
7.3.10.3.Rest of Europe market size and forecast, by application
7.4.Asia-Pacific
7.4.1.Asia-Pacific market size and forecast, by product
7.4.2.Asia-Pacific market size and forecast, by method
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by country
7.4.5.Japan
7.4.5.1.Japan market size and forecast, by product
7.4.5.2.Japan market size and forecast, by method
7.4.5.3.Japan market size and forecast, by application
7.4.6.China
7.4.6.1.China market size and forecast, by product
7.4.6.2.China market size and forecast, by method
7.4.6.3.China market size and forecast, by application
7.4.7.Australia
7.4.7.1.Australia market size and forecast, by product
7.4.7.2.Australia market size and forecast, by method
7.4.7.3.Australia market size and forecast, by application
7.4.8.India
7.4.8.1.India market size and forecast, by product
7.4.8.2.India market size and forecast, by method
7.4.8.3.India market size and forecast, by application
7.4.9.South Korea
7.4.9.1.South Korea market size and forecast, by product
7.4.9.2.South Korea market size and forecast, by method
7.4.9.3.South Korea market size and forecast, by application
7.4.10.Rest of Asia-Pacific
7.4.10.1.Rest of Asia-Pacific market size and forecast, by product
7.4.10.2.Rest of Asia-Pacific market size and forecast, by method
7.4.10.3.Rest of Asia-Pacific market size and forecast, by application
7.5.LAMEA
7.5.1.LAMEA market size and forecast, by product
7.5.2.LAMEA market size and forecast, by method
7.5.3.LAMEA market size and forecast, by application
7.5.4.LAMEA market size and forecast, by country
7.5.5.Brazil
7.5.5.1.Brazil market size and forecast, by product
7.5.5.2.Brazil market size and forecast, by method
7.5.5.3.Brazil market size and forecast, by application
7.5.6.Saudi Arabia
7.5.6.1.Saudi Arabia market size and forecast, by product
7.5.6.2.Saudi Arabia market size and forecast, by method
7.5.6.3.Saudi Arabia market size and forecast, by application
7.5.7.South Africa
7.5.7.1.South Africa market size and forecast, by product
7.5.7.2.South Africa market size and forecast, by method
7.5.7.3.South Africa market size and forecast, by application
7.5.8.Rest of LAMEA
7.5.8.1.Rest of LAMEA market size and forecast, by product
7.5.8.2.Rest of LAMEA market size and forecast, by method
7.5.8.3.Rest of LAMEA market size and forecast, by application
CHAPTER 8:COMPANY PROFILES
8.1.AUTOBIO DIAGNOSTICS CO. LTD
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments
8.2.BECTON, DICKINSON AND COMPANY
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.BIOM?RIEUX SA
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.BRUKER CORPORATION
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.F. HOFFMANN-LA ROCHE LTD
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.LUMINEX CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.NEOGEN Corporation (Abtek Biologicals)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.OPGEN INC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.T2 BIOSYSTEMS, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s Five Forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of infectious diseases, bloodstream infection and sepsis
3.5.1.2.Rise in demand for advanced diagnostic techniques
3.5.1.3.Increase in R&D activities and strict regulation from government
3.5.1.4.Growing worldwide geriatric population
3.5.2.Restraints
3.5.2.1.High cost of automated blood culture instruments
3.5.2.2.Lack of skilled professionals and laboratory technicians
3.5.3.Opportunity
3.5.3.1.Increase in adoption of new technology
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the blood culture tests market
CHAPTER 4:BLOOD CULTURE TEST, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Market size and forecast, by region
4.2.2.Market analysis, by country
4.3.Instruments
4.3.1.Market size and forecast, by region
4.3.2.Market analysis, by country
4.4.Software and Services
4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country
CHAPTER 5:BLOOD CULTURE TESTS MARKET, BY METHOD
5.1.Overview
5.1.1.Market size and forecast
5.2.Conventional
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Automated
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:BLOOD CULTURE TESTS MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Bacterial
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Fungal
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Other
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:BLOOD CULTURE TEST MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.North America market size and forecast, by product
7.2.2.North America market size and forecast, by method
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by country
7.2.5.U.S.
7.2.5.1.U.S. market size and forecast, by product
7.2.5.2.U.S. market size and forecast, by method
7.2.5.3.U.S. market size and forecast, by application
7.2.6.Canada
7.2.6.1.Canada market size and forecast, by product
7.2.6.2.Canada market size and forecast, by method
7.2.6.3.Canada market size and forecast, by application
7.2.7.Mexico
7.2.7.1.Mexico market size and forecast, by product
7.2.7.2.Mexico market size and forecast, by method
7.2.7.3.Mexico market size and forecast, by application
7.3.Europe
7.3.1.Europe market size and forecast, by product
7.3.2.Europe market size and forecast, by method
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by country
7.3.5.Germany
7.3.5.1.Germany market size and forecast, by product
7.3.5.2.Germany market size and forecast, by method
7.3.5.3.Germany market size and forecast, by application
7.3.6.France
7.3.6.1.France market size and forecast, by product
7.3.6.2.France market size and forecast, by method
7.3.6.3.France market size and forecast, by application
7.3.7.UK
7.3.7.1.UK market size and forecast, by product
7.3.7.2.UK market size and forecast, by method
7.3.7.3.UK market size and forecast, by application
7.3.8.Italy
7.3.8.1.Italy market size and forecast, by product
7.3.8.2.Italy market size and forecast, by method
7.3.8.3.Italy market size and forecast, by application
7.3.9.Spain
7.3.9.1.Spain market size and forecast, by product
7.3.9.2.Spain market size and forecast, by method
7.3.9.3.Spain market size and forecast, by application
7.3.10.Rest of Europe
7.3.10.1.Rest of Europe market size and forecast, by product
7.3.10.2.Rest of Europe market size and forecast, by method
7.3.10.3.Rest of Europe market size and forecast, by application
7.4.Asia-Pacific
7.4.1.Asia-Pacific market size and forecast, by product
7.4.2.Asia-Pacific market size and forecast, by method
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by country
7.4.5.Japan
7.4.5.1.Japan market size and forecast, by product
7.4.5.2.Japan market size and forecast, by method
7.4.5.3.Japan market size and forecast, by application
7.4.6.China
7.4.6.1.China market size and forecast, by product
7.4.6.2.China market size and forecast, by method
7.4.6.3.China market size and forecast, by application
7.4.7.Australia
7.4.7.1.Australia market size and forecast, by product
7.4.7.2.Australia market size and forecast, by method
7.4.7.3.Australia market size and forecast, by application
7.4.8.India
7.4.8.1.India market size and forecast, by product
7.4.8.2.India market size and forecast, by method
7.4.8.3.India market size and forecast, by application
7.4.9.South Korea
7.4.9.1.South Korea market size and forecast, by product
7.4.9.2.South Korea market size and forecast, by method
7.4.9.3.South Korea market size and forecast, by application
7.4.10.Rest of Asia-Pacific
7.4.10.1.Rest of Asia-Pacific market size and forecast, by product
7.4.10.2.Rest of Asia-Pacific market size and forecast, by method
7.4.10.3.Rest of Asia-Pacific market size and forecast, by application
7.5.LAMEA
7.5.1.LAMEA market size and forecast, by product
7.5.2.LAMEA market size and forecast, by method
7.5.3.LAMEA market size and forecast, by application
7.5.4.LAMEA market size and forecast, by country
7.5.5.Brazil
7.5.5.1.Brazil market size and forecast, by product
7.5.5.2.Brazil market size and forecast, by method
7.5.5.3.Brazil market size and forecast, by application
7.5.6.Saudi Arabia
7.5.6.1.Saudi Arabia market size and forecast, by product
7.5.6.2.Saudi Arabia market size and forecast, by method
7.5.6.3.Saudi Arabia market size and forecast, by application
7.5.7.South Africa
7.5.7.1.South Africa market size and forecast, by product
7.5.7.2.South Africa market size and forecast, by method
7.5.7.3.South Africa market size and forecast, by application
7.5.8.Rest of LAMEA
7.5.8.1.Rest of LAMEA market size and forecast, by product
7.5.8.2.Rest of LAMEA market size and forecast, by method
7.5.8.3.Rest of LAMEA market size and forecast, by application
CHAPTER 8:COMPANY PROFILES
8.1.AUTOBIO DIAGNOSTICS CO. LTD
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments
8.2.BECTON, DICKINSON AND COMPANY
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.BIOM?RIEUX SA
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.BRUKER CORPORATION
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.F. HOFFMANN-LA ROCHE LTD
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.LUMINEX CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.NEOGEN Corporation (Abtek Biologicals)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.OPGEN INC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.T2 BIOSYSTEMS, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.GLOBAL BLOOD CULTURE TEST MARKET FOR CONSUMABLES, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL BLOOD CULTURE TEST MARKET FOR INSTRUMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BLOOD CULTURE TEST MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL BLOOD CULTURE TESTS MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 06.GLOBAL BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL BLOOD CULTURE TESTS MARKET FOR AUTOMATED , BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.GLOBAL BLOOD CULTURE TESTS MARKET FOR BACTERIAL, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL BLOOD CULTURE TESTS MARKET FOR FUNGAL, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GLOBAL BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIA DETECTION, BY REGION, 2019–2027 ($MILLION)
TABLE 12.BLOOD CULTURE TEST MARKET, BY REGION, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 15.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 16.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 17.U.S. BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 18.U.S. BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
U.S BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 19.CANADA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 20.CANADA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 21.CANADA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 22.MEXICO BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 23.MEXICO BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 24.MEXICO BLOOD CULTURE TEST MARKET, BY APPLICATIONE, 2019-2027, ($MILLION)
TABLE 25.EUROPE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 26.EUROPE BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 27.EUROPE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 28.EUROPE BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 29.GERMANY BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 30.GERMANY BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 31.GERMANY BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 32.FRANCE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 33.FRANCE BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 34.FRANCE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 35.UK BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 36.UK BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 37.UK BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 38.ITALY BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 39.ITALY BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 40.ITALY BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 41.SPAIN BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 42.SPAIN BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 43.SPAIN BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 44.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 45.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 46.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 47.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 48.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 49.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 50.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 51.JAPAN BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 52.JAPAN BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 53.JAPAN BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 54.CHINA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 55.CHINA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 56.CHINA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 57.AUSTRALIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 58.AUSTRALIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 59.AUSTRALIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 60.INDIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 61.INDIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 62.INDIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 63.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 64.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 65.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 69.LAMEA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 70.LAMEA BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 71.LAMEA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 72.LAMEA BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 73.BRAZIL BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 74.BRAZIL BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 75.BRAZIL BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 76.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 77.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 78.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 79.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 80.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 81.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 82.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 83.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 84.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 85.AUTOBIO: COMPANY SNAPSHOT
TABLE 86.AUTOBIO: OPERATING SEGMENTS
TABLE 87.AUTOBIO: PRODUCT PORTFOLIO
TABLE 88.AUTOBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.BD: COMPANY SNAPSHOT
TABLE 90.BD: OERATING SEGMENT
TABLE 91.BD: PRODUCT PORTFOLIO
TABLE 92.BIOM?RIEUX: COMPANY SNAPSHOT
TABLE 93.BIOM?RIEUX: OPERATING SEGMENTS
TABLE 94.BIOM?RIEUX: PRODUCT PORTFOLIO
TABLE 95.BIOM?RIEUX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.BRUKER: COMPANY SNAPSHOT
TABLE 97.BRUKER: OPERATING BUSINESS SEGMENTS
TABLE 98.BRUKER: PRODUCT PORTFOLIO
TABLE 99.BRUKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.ROCHE: COMPANY SNAPSHOT
TABLE 101.ROCHE : OPERATING SEGMENTS
TABLE 102.ROCHE : PRODUCT PORTFOLIO
TABLE 103.ROCHE : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104.LUMINEX: COMPANY SNAPSHOT
TABLE 105.LUMINEX: OPERATING SEGMENTS
TABLE 106.LUMINEX: PRODUCT PORTFOLIO
TABLE 107.LUMINEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108.NEOGEN: COMPANY SNAPSHOT
TABLE 109.NEOGEN: OPERATING SEGMENT
TABLE 110.NEOGEN: PRODUCT PORTFOLIO
TABLE 111.NEOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112.OPGEN : COMPANY SNAPSHOT
TABLE 113.OPGEN: OPERATING SEGMENTS
TABLE 114.OPGEN: PRODUCT PORTFOLIO
TABLE 115.T2 BIOSYSTEMS: COMPANY SNAPSHOT
TABLE 116.T2 BIOSYSTEMS: OPERATING SEGMENTS
TABLE 117.T2 BIOSYSTEMS : PRODUCT PORTFOLIO
TABLE 118.T2 BIOSYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.THERMO FISHER: COMPANY SNAPSHOT
TABLE 120.THERMO FISHER.: OPERATING SEGMENTS
TABLE 121.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 122.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 01.GLOBAL BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.GLOBAL BLOOD CULTURE TEST MARKET FOR CONSUMABLES, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL BLOOD CULTURE TEST MARKET FOR INSTRUMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BLOOD CULTURE TEST MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL BLOOD CULTURE TESTS MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 06.GLOBAL BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL BLOOD CULTURE TESTS MARKET FOR AUTOMATED , BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.GLOBAL BLOOD CULTURE TESTS MARKET FOR BACTERIAL, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL BLOOD CULTURE TESTS MARKET FOR FUNGAL, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GLOBAL BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIA DETECTION, BY REGION, 2019–2027 ($MILLION)
TABLE 12.BLOOD CULTURE TEST MARKET, BY REGION, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 15.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 16.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 17.U.S. BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 18.U.S. BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
U.S BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 19.CANADA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 20.CANADA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 21.CANADA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 22.MEXICO BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 23.MEXICO BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 24.MEXICO BLOOD CULTURE TEST MARKET, BY APPLICATIONE, 2019-2027, ($MILLION)
TABLE 25.EUROPE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 26.EUROPE BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 27.EUROPE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 28.EUROPE BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 29.GERMANY BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 30.GERMANY BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 31.GERMANY BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 32.FRANCE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 33.FRANCE BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 34.FRANCE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 35.UK BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 36.UK BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 37.UK BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 38.ITALY BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 39.ITALY BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 40.ITALY BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 41.SPAIN BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 42.SPAIN BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 43.SPAIN BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 44.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 45.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 46.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 47.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 48.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 49.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 50.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 51.JAPAN BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 52.JAPAN BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 53.JAPAN BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 54.CHINA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 55.CHINA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 56.CHINA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 57.AUSTRALIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 58.AUSTRALIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 59.AUSTRALIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 60.INDIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 61.INDIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 62.INDIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 63.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 64.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 65.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 69.LAMEA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 70.LAMEA BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 71.LAMEA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 72.LAMEA BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 73.BRAZIL BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 74.BRAZIL BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 75.BRAZIL BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 76.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 77.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 78.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 79.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 80.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 81.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 82.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 83.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 84.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 85.AUTOBIO: COMPANY SNAPSHOT
TABLE 86.AUTOBIO: OPERATING SEGMENTS
TABLE 87.AUTOBIO: PRODUCT PORTFOLIO
TABLE 88.AUTOBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.BD: COMPANY SNAPSHOT
TABLE 90.BD: OERATING SEGMENT
TABLE 91.BD: PRODUCT PORTFOLIO
TABLE 92.BIOM?RIEUX: COMPANY SNAPSHOT
TABLE 93.BIOM?RIEUX: OPERATING SEGMENTS
TABLE 94.BIOM?RIEUX: PRODUCT PORTFOLIO
TABLE 95.BIOM?RIEUX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.BRUKER: COMPANY SNAPSHOT
TABLE 97.BRUKER: OPERATING BUSINESS SEGMENTS
TABLE 98.BRUKER: PRODUCT PORTFOLIO
TABLE 99.BRUKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.ROCHE: COMPANY SNAPSHOT
TABLE 101.ROCHE : OPERATING SEGMENTS
TABLE 102.ROCHE : PRODUCT PORTFOLIO
TABLE 103.ROCHE : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104.LUMINEX: COMPANY SNAPSHOT
TABLE 105.LUMINEX: OPERATING SEGMENTS
TABLE 106.LUMINEX: PRODUCT PORTFOLIO
TABLE 107.LUMINEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108.NEOGEN: COMPANY SNAPSHOT
TABLE 109.NEOGEN: OPERATING SEGMENT
TABLE 110.NEOGEN: PRODUCT PORTFOLIO
TABLE 111.NEOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112.OPGEN : COMPANY SNAPSHOT
TABLE 113.OPGEN: OPERATING SEGMENTS
TABLE 114.OPGEN: PRODUCT PORTFOLIO
TABLE 115.T2 BIOSYSTEMS: COMPANY SNAPSHOT
TABLE 116.T2 BIOSYSTEMS: OPERATING SEGMENTS
TABLE 117.T2 BIOSYSTEMS : PRODUCT PORTFOLIO
TABLE 118.T2 BIOSYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.THERMO FISHER: COMPANY SNAPSHOT
TABLE 120.THERMO FISHER.: OPERATING SEGMENTS
TABLE 121.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 122.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.GLOBAL BLOOD CULTURE TESTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR AUTOMATED , BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR BACTERIAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR FUNGAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIA DETECTION, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 23.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 24.BIOM?RIEUX: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.BIOM?RIEUX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 26.BIOM?RIEUX: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.BRUKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.BRUKER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.BRUKER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 30.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.ROCHE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 32.ROCHE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.LUMINEX: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.LUMINEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.LUMINEX: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.NEOGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.NEOGEN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 38.NEOGEN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 39.OPGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.OPGEN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.T2 BIOSYSTEMS: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.T2 BIOSYSTEMS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.T2 BIOSYSTEMS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 01.GLOBAL BLOOD CULTURE TESTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR AUTOMATED , BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR BACTERIAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR FUNGAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIA DETECTION, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 23.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 24.BIOM?RIEUX: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.BIOM?RIEUX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 26.BIOM?RIEUX: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.BRUKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.BRUKER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.BRUKER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 30.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.ROCHE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 32.ROCHE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.LUMINEX: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.LUMINEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.LUMINEX: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.NEOGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.NEOGEN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 38.NEOGEN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 39.OPGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.OPGEN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.T2 BIOSYSTEMS: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.T2 BIOSYSTEMS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.T2 BIOSYSTEMS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
